The Pharmacology of Indomethacin

  title={The Pharmacology of Indomethacin},
  author={Sylvia M Lucas},
  journal={Headache: The Journal of Head and Face Pain},
  • S. Lucas
  • Published 1 February 2016
  • Medicine
  • Headache: The Journal of Head and Face Pain
Over 50 years ago, indomethacin emerged as an extremely potent non‐steroidal anti‐inflammatory drug (NSAID) during a massive effort to find effective anti‐inflammatory and analgesic medications. The 1960s saw acetic acid derivatives developed into indomethacin, diclofenac, and sulindac, and propionic derivatives into ibuprofen, naproxen, and ketoprofen. Indomethacin was likely the most potent of these compounds and one of the earliest to enter clinical trials. It is not surprising that… 
Lipid Formulations and Bioconjugation Strategies for Indomethacin Therapeutic Advances
This review summarizes pharmacological information about IND and analyzes its new lipid formulations and lipid bioconjugates as well as discuss their efficacy and potential application.
Review of characteristics and analytical methods for determination of indomethacin
Indomethacin (INDO) is one of the most powerful drugs used in various clinical trials and therapies related to the mechanism of blocking prostaglandin synthesis, thus reducing and eliminating many inflammatory conditions in patients.
Limitations of drug concentrations used in cell culture studies for understanding clinical responses of NSAIDs.
In this review, the in vitro cellular effects of six nonsteroidal anti-inflammatory drugs (NSAIDs), salicylate, ibuprofen, naproxen, indomethacin, celecoxib and diclofenac, are examined. Inhibition
Etoricoxib and celecoxib sensitive indomethacin‐responsive headache disorders
Etoricoxib and celecoxib, selective inhibitors of cyclo‐oxygenase‐2 (COX‐2), spare gastroduodenal COX‐1 activity and are less likely to cause gastrointestinal adverse effects than indomethacin.
Using Experimental Models to Decipher the Effects of Acetaminophen and NSAIDs on Reproductive Development and Health
The mechanisms by which NSAIDs and analgesics may impair gonadal development and maturation, puberty development, sex hormone production, maturation and function of adult organs, and ultimately fertility in the exposed animals and their offspring are discussed.
Indomethacin‐responsive headaches—A narrative review
The so‐called indomethacin‐responsive headache disorders consist of a group of conditions with a very different presentation that have a particularly good response to indomethin, so distinct as to be used in the definition of two: hemicrania continua and paroxysmal hemic Brania.
Anti-inflammatory, Analgesic, and Cytotoxic Effects of The Phytexponent: A Polyherbal Formulation
The Phytexponent has significant in vivo anti-inflammatory and analgesic efficacy in mice models and is not cytotoxic to Vero E6 cell line, depicting its therapeutic potential upon further empirical investigation.
Quantitative determination of new anti-inflammatory drug indomenthyl and its metabolite in rabbit plasma by HPLC-MS/MS.
This research is aimed at developing a highly sensitive method for the quantitative determination of indomenthyl and its active metabolite indomethacin in rabbit plasma by HPLC-MS/MS.
Ameliorative effects of indomethacin at different concentrations on endothelial insulin resistance through two distinct pathways.


Suprofen: the pharmacology and clinical efficacy of a new non-narcotic peripheral analgesic.
Suprofen appears to be equal or greater in efficacy as an analgesic modality than those of ibuprofen, propoxyphene, naproxen and diflunisal or a combination of 650 mg aspirin plus 60 mg codeine.
A potential nitrergic mechanism of action for indomethacin, but not of other COX inhibitors: relevance to indomethacin-sensitive headaches
In vivo technique of intravital microscopy in rats has been utilised as a model of trigeminovascular nociception to study the potential mechanism of action of indomethacin, potentially relevant to understanding its unique action in disorders such as paroxysmal hemicrania and he Micrania continua.
Mechanism of action of antiinflammatory drugs.
The hypothesis is that the unwanted side effects of NSAIDs, such as damage to the gastric mucosa and kidneys, are due to their ability to inhibit COX-1, while their antiinflammatory (therapeutic effects) aredue to inhibition ofCOX-2.
Clinical Pharmacokinetics of Indomethacin
It is found that probenecid results in increased plasma concentrations of indomethacin with enhanced pain relief without increasing the incidence of side effects, and concomitant ingestion of food reduces and delays the peak concentrations without reducing the amount absorbed.
Are altered pharmacokinetics of non-steroidal anti-inflammatory drugs (NSAIDs) a risk factor for gastrointestinal bleeding?
The hypothesis that reduced clearance of NSAIDs, which results in higher plasma concentrations, is a risk factor for acute gastrointestinal haemorrhage has failed to support.
Mechanism of action of anti-inflammatory drugs.
  • J. Vane, R. Botting
  • Biology, Medicine
    Advances in experimental medicine and biology
  • 1997
The activity of a number of NSAIDs has been investigated in several test systems, showing that most of those marketed have higher activities against COX-1 or are equipotent against both isoform, and there are several new non-steroidal COx-2 inhibitors in development.
Indomethacin in rheumatoid arthritis: comparison of oral and rectal dosing.
Indomethacin 100 mg nightly by mouth is as effective as a 100 mg suppository and easier to administer and no significant difference was seen in the side effects experienced in the two periods.
Pharmacokinetic overview of indomethacin and sustained-release indomethacin.
  • K. Yeh
  • Medicine, Biology
    The American journal of medicine
  • 1985
Design and synthesis of indomethacin analogues that inhibit P-glycoprotein and/or multidrug resistant protein without COX inhibitory activity.
Evaluation of the inhibitory effects of conformationally restricted analogues and regioisomers of the nonsteroidal anti-inflammatory drug indomethacin indicated that NSAIDS modulation of multidrug-resistant P-glycoprotein and multidrog-resistant protein-1 is not associated with COX-1 and COX2 inhibitory activities.